Presented by
Management Forum
A Practical Guide to Writing Risk Management Plans (RMPs) Training Course
Understand the relationship between RMPs and safety reviews; PBRERs/DSURs; licence submissions (CTD) and their maintenance.
★★★★★ "Specific, accurate and useful."
9 October 2024
+ 21 March 2025, 11 July 2025, 12 November 2025 »
from £549
- Format: Live online
- CPD: 6 hours for your records
- Certificate of completion
Course overview
In the EU, all companies are required to provide risk management plans (RMPs) for every new product, whether generic products or new chemical entities, and these RMPs must also be modified and updated throughout the lifetime of a medicine. This intensive one-day course will provide you with an invaluable overview of writing and maintaining RMPs, with practical advice to ensure you achieve regulatory compliance. You will discuss best practice for using the EU templates and risk minimisation tools to enhance the benefit/risk of your product.
The programme has been fully revised to cover the latest updates and new requirements, including amendments made to the previous template.
This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.
Benefits of attending
- Gain an overview of ICH and EU RMPs – their production and ongoing maintenance
- Clarify the documentation to be supplied to regulators and the process for RMPs
- Learn what happened in the EU RMP update and explore the new requirements
- Discuss the EU templates and their completion – generic and innovator products
- Understand the relationship between RMPs, post-authorisation safety and efficacy studies, safety reviews and PBRERs
- Discuss the RMP and risk minimisation follow-up
Who should attend?
This course will be relevant for those working in pharmacovigilance who are involved with writing RMPs, including medical directors/QPPVs who approve such plans. It will also be of interest to those who work with pharmacovigilance, eg in regulatory affairs, clinical, pre-clinical, sales and marketing, legal, commercial and quality.
This course will cover:
Introduction, welcome and objectives
An introduction to RMPs
- Outline and purpose of ICH E2E
- The implementation of ICH E2E
- National adoption of ICH E2E
- Europe
- USA
- Japan
- Arab States
Outline of EU RMPs
- The current EU module V requirements
- Generic, innovator and advanced therapy products
- Additional documents to supply to the regulators
- Safety reporting timelines for RMPs
- EU RMP update and new requirements
The EU templates and their completion – generic and innovator products
- The EU generic template – EU requirements (module V)
- The EU generic RMP versus innovator RMP
- The EU template for innovator products
Completion of RMPs in other countries
The EU RMP and relationship with other documents
- The RMP post-authorisation safety and efficacy studies
- The RMP and PBRERs
- The RMP and safety reviews
The RMP and Risk Minimisation Follow up
Overview of the sections of the EU RMP template
- Part I – Product overview
- Part II – Safety specification modules SI-SVIII
- Part III – Pharmacovigilance plan including safety studies
- Part IV – Plans for post-authorisation efficacy studies
- Part V – Risk minimisation activities including effectiveness measures
- Part VI – Summary of the risk management plan
- Part VII – Annexes
Final discussion session
Graeme Ladds
PharSafer Associates Ltd
Graeme Ladds, Director of PharSafer, has over 30 years’ experience working in the pharmaceutical industry. Having started his career at Ashbourne Pharmaceuticals in 1989 as Head of Drug Safety & Medical Information, he went on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals. He then set up his consultancy and specialist CRO company, PharSafer Associates Ltd, where he has been involved in establishing pharmacovigilance in companies, performing audits across Europe and the USA, SOP writing, acting as QP for companies, and helping with regulatory inspections.
NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:
- 30% off the 2nd delegate*
- 40% off the 3rd delegate*
- 50% off the 4th delegate*
Please contact us for pricing if you are interested in booking 5 or more delegates
9 October 2024
Live online
09:00-16:30 UK (London) (UTC+01)
10:00-17:30 Paris (UTC+02)
04:00-11:30 New York (UTC-04)
Course code 13923
- GBP 649
- EUR 929
- USD 1,049
- 1 day live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
21 March 2025
Live online
09:00-16:30 UK (London) (UTC+00)
10:00-17:30 Paris (UTC+01)
05:00-12:30 New York (UTC-04)
Course code 14437
- GBP 549 649
- EUR 789 929
- USD 893 1,049
Until 14 Feb
- 1 day live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
11 July 2025
Live online
09:00-16:30 UK (London) (UTC+01)
10:00-17:30 Paris (UTC+02)
04:00-11:30 New York (UTC-04)
Course code 14885
- GBP 549 649
- EUR 789 929
- USD 893 1,049
Until 06 Jun
- 1 day live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
12 November 2025
Live online
09:00-16:30 UK (London) (UTC+00)
10:00-17:30 Paris (UTC+01)
04:00-11:30 New York (UTC-05)
Course code 14988
- GBP 549 649
- EUR 789 929
- USD 893 1,049
Until 08 Oct
- 1 day live online training
- Browser-based, no download usually required
- See presenters and interact with fellow attendees
- Download documentation and certification of completion
- Fair transfer and cancellation policy
Not ready to book yet?
for 7 days, no obligation
* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.
Reviews of IPI's A Practical Guide to Writing Risk Management Plans (RMPs) training course
Specific, accurate and useful.
Oct 5 2023
Valdas Liukaitis 
SMCA of Lithuania
Jan 19 2023
Experienced and knowledgeable speaker. Answered all questions and presented in a clear and concise manner.
Sheraz Hussain 
Snr PV PM, N/A
Jul 11 2022
Excellent speaker who managed to keep the listener's attention through a complex document and process. Very useful slides that I will consult when requested assistance with RMP from clients. I particularly enjoyed the explanation of US vs Japan vs EU expectations in terms of safety.
Magali Le Goff 
Director Scientific Writing & Regulatory Sciences, BlueReg
Jan 13 2022
The presentation was very clear with lots of examples
Liji Sasidharan
Senior Manager Benefit-Risk team, Diamond Pharma Services (A Propharma Group Company)
Jan 13 2022
The presentation was very clear with lots of examples.
Liji Sasidharan
Senior Manager Benefit-Risk team, Diamond Pharma Services (A Propharma Group Company)
Jan 28 2021
Content, presentations and speaker was exceptional.
Anna Shimbulu 
Medicines Information and Safety Pharmacist, Therapeutics Information and Pharmacovigilance Centre
Jan 28 2021
It was very informative. The speaker has in depth knowledge of various other country regulations, which helps the trainees to gain more information.
Srinivas Ramesh
National Safety and Regulatory Officer, Fresenius Kabi Ltd & Calea UK Ltd
Jan 28 2021
Really great speaker, I loved his examples and he made the presentation super interesting!
Maja Susa
Safety Specialist III,
Jan 28 2021
Very good. Excellent speaker with vast experience,
Pankaj Gowari 
Team Leader - Product Safety and Risk management, apotex research private limited
Jan 27 2020
Graeme was an extremely knowledgeable source who focused on imparting the most important information for us to understand the RMP writing process. I was looking to gain a better understanding of preparing RMPs in accordance with legislation and I believe that Graeme did an excellent job in providing this.
Rex Alexander 
Pharmacovigilance Compliance Manager - EUPV, APL Swift Services (Malta) Ltd
Jan 27 2020
Very good course that gave an overall understanding of the RMP and its purpose, presented by a very good communicator with many years of experience.
Tina Maria Greve 
Drug Safety Advisor, ALK-Abello A/S
Jan 27 2020
I found the course worthwhile. The presenter was easy to follow and gave practical examples which I found useful.
Laura Maginley
Manager, EU Regulatory Sciences, Biogen
Jan 28 2019
Overall, I'm satisfied with the course and think the sequence of the course topics was very logical and organised.
Rania Ali 
Senior Safety Associate, Amgen
Jan 28 2019
The course was fast paced, but if we had questions Graeme went back over and clarified, which I appreciated as I didn't share the same background as most of the other course candidates. I walk away with a clear understanding of the guidance behind and purpose of Risk Management Plans.
Jennifer Hynes
Quality Manager, Benchmark Vaccines Limited
Jul 4 2018
Very knowledgable about [the] subject area. Good content and interesting presentation and speaker.
Harriet Gillespie
Senior Medical Writing Scientist, Janssen-Cilag Limited
Jan 29 2018
I enjoyed Graeme's real-world examples. He addresses people with different knowledge abilities very well.
Alice King
Regulatory Affairs Associate, Creo Pharma Ltd
Jan 29 2018
Overall a well organized course providing relevant knowledge about preparing RMPs. The presentation was good and the presenter has a substantial experience in the field of PV.
Gabor Varbiro
Medical Adviser, Wockhardt UK Ltd
Jul 4 2018
Very knowledgeable. Very well presented and in-depth description presented on each section.
Claire McLaughlin
Drug Safety Specialist, Kyowa Kirin International
Jan 29 2018
Good course, would recommend it to others as well. Speakers well prepared and the presentation was good.
Gabor Varbiro
Medical Adviser, Wockhardt UK Ltd
Jul 4 2016
Fantastic!
Yusouf Bah
Drug Safety and Pharmacovigilance Manager, DBV Technologies
Jul 4 2016
I have always found Management Forum courses to be of a high standard. They are my preferred teaching and training source for staff at Redline PV.
Shirley-Ann van der Spuy
Managing Director & EU QPPV, Red Line Pharmacovigilance Ltd
Jul 4 2016
Very useful and engaging.
Lauren Tuitt
ProductLife
Jul 4 2016
Good course, good topic. The speaker is excellent and has great experience.
Jorge Ignacio Gonzalez Borroto 
Pharmacovigilance Officer, Grupo Ferrer Internacional SA
United Kingdom
- A Nelson & Co Ltd
- Accord-UK Ltd
- Alander Consulting Limited
- Alliance Healthcare
- Almac Group Ltd
- Benchmark Vaccines Limited
- Biogen
- Boots
- consilient health
- Creo Pharma Ltd
- DA Consulting Ltd
- Dermal Laboratories Limited
- Diamond Pharma Services
- Diamond Pharma Services (A Propharma Group Company)
- Fresenius Kabi Ltd & Calea UK Ltd
- Griffiths Medical Writing Ltd
- Haleon
- Icon Clinical Research (UK) Limited
- Janssen-Cilag Limited
- JensonR+ Ltd
- Kem Pharmaceuticals Limited
- Kyowa Kirin International
- Mapi Life Sciences Canada Inc.
- Mediplex Ltd
- N/A
- NDA Regulatory Services
- Norgine
- Norgine Ltd
- Panacea Pharma Projects
- Pharmacosmos UK
- Pharmacovigilance Matters Limited
- ProductLife
- PTC Therapeutics
- Red Line Pharmacovigilance Ltd
- Roche Products Ltd
- Rosemont Pharmaceuticals Ltd
- The Boots Company PLC
- Veterinary Medicines Directorate
- Wockhardt UK Ltd
Spain
- Chemo Research S.L.
- Eignapharma
- Faes Farma
- FAES FARMA SA
- Ferrer Interancional, S.A.
- Grifols
- Grupo Ferrer Internacional SA
- Pharma Mar, S.A.
- PharmaMar
Italy
- Alfa Wassermann S.p.A.
- Alfasigma S.p.A.
- Alfasigma Spa
- Alfrapharma Srl
- Chiesi Farmaceutici S.p.a.
- Recordati
- recordati spa
- ZAMBON SPA
France
- Allergan France S.A.S.
- BlueReg
- BlueReg Pharma Consulting
- DBV Technologies
- INNATE PHARMA
- Pierre Fabre S.A.
Denmark
- 2care4 Generics ApS
- ALK-Abello A/S
- Jacobsen Pharma & MedTech Advice A/S
- LINK Medical ApS
- VAN Pharma Consult
Belgium
- Colgate-Palmolive R&D
- Conforma NV
- Emtex BVBA
- Janssen Pharmaceutica NV
Germany
- CHEPLAPHARM Arzneimittel GmbH
- Medac GmbH
- MorphoSys AG
India
- apotex research private limited
- Parexel
- Parexel International
Ireland
- Amryt Pharmaceuticals DAC
- Aspen Pharma Trading Ltd
- Real Regulatory Ltd
Lithuania
- SMCA of Lithuania
- State Medicines Control Agency of Lithuania
Switzerland
- Idorsia Pharmaceuticals Ltd
- Swedish Orphan Biovitrum AG
Bulgaria
- Iggea Ltd
China
- Roche (China) Holding Ltd
Egypt
- Amgen
Greece
- ELPEN PHARMACEUTICAL CO.INC.
Isle of Man
- Panacea Pharma Projects
Israel
- Kamada LTD
Korea, Democratic People's Republic Of
- Archigen Biotech Limited
Malta
- APL Swift Services (Malta) Ltd
Namibia
- Therapeutics Information and Pharmacovigilance Centre
Netherlands
- Sanquin Plasma Products
Poland
- Covance
Slovak Republic
- Ewopharma International s.r.o
United States of America
- Sierra Oncology
Run A Practical Guide to Writing Risk Management Plans (RMPs) Live online for your team
1 day
Typical duration
Pricing from:
- GBP 450
- Per attendee, based on 10 attendees
- Course tailored to your requirements
- At your choice of location, or online
We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.
Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:
